Head-to-head · Value Score
CoreAge Rx vs Roen Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Roen Rx a 68. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameRoen Rx
#279 · Grade C · Watch List
Est. first month
From $216/mo (plus a separate fee, compounded)
Save ~84% vs brand-nameFDA warning letter. The FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026. Check it on the FDA database.
Get this deal Full Roen Rx review →The verdict
CoreAge Rx takes it on Value Score, 93 to 68 — an est. $99/mo first month, with no teaser step-up baked in. Roen Rx isn't out of it: Someone with insurance worth testing against a brand-name GLP-1, who will count the membership separately.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Roen Rx |
|---|---|---|
| Value Score | 93 (A+) | 68 (C) |
| Est. first month | $99/mo | From $216/mo (plus a separate fee, compounded) |
| Save vs brand-name | ~89% | ~84% |
| Semaglutide | $99/mo | From $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | $149/mo | From $216/mo (plus a separate fee, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states and DC |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Roen Rx
Roen Rx is a multi-service telehealth platform offering compounded semaglutide alongside brand-name Ozempic, Wegovy, Zepbound and Mounjaro with insurance coordination, across all 50 states and DC.
Why it's a deal
- Covers all 50 states and the District of Columbia, with free consultations and ongoing licensed-provider support
- Carries all four brand-name GLP-1s beside the compounded option and will coordinate with insurance on them
- Compounded and brand-name routes sit on one account, so switching does not mean starting over elsewhere
The fine print
- A separate membership is charged alongside the medication — $39 for the first month — and the GLP-1 medication is not included in it
- Insurance coordination will not work for every plan, and the site does not say which it has succeeded with
- GLP-1s sit inside a broad catalog covering ED, hair loss, skincare and birth control rather than being the focus
- The compounded semaglutide rate needs a three-month plan to reach its advertised figure
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Roen Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.